CO2022013187A2 - Medicamentos antivirales para el tratamiento y prevención de la infección por vih - Google Patents

Medicamentos antivirales para el tratamiento y prevención de la infección por vih

Info

Publication number
CO2022013187A2
CO2022013187A2 CONC2022/0013187A CO2022013187A CO2022013187A2 CO 2022013187 A2 CO2022013187 A2 CO 2022013187A2 CO 2022013187 A CO2022013187 A CO 2022013187A CO 2022013187 A2 CO2022013187 A2 CO 2022013187A2
Authority
CO
Colombia
Prior art keywords
prevention
treatment
hiv
hiv infection
antiviral drugs
Prior art date
Application number
CONC2022/0013187A
Other languages
English (en)
Inventor
Alexander Vitalievich Kurkin
Ekaterina Vladimirovna Manasova
Denis Nikolaevich Kazyulkin
Vladimir Nikolaevich Ivanov
Mikhail Gennadievich Shurygin
Original Assignee
Pharmasyntez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2020107455A external-priority patent/RU2780101C2/ru
Application filed by Pharmasyntez filed Critical Pharmasyntez
Publication of CO2022013187A2 publication Critical patent/CO2022013187A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención pertenece a los derivados de pirimidina con propiedades inhibidoras de la replicación del VIH. La invención incluye nuevas composiciones de pirimidina de fórmula I para el tratamiento y prevención de las infecciones por el VIH. La invención también incluye los métodos de producción de las mismas y las composiciones farmacéuticas que las contienen. La invención también se refiere a la administración de estas composiciones para el tratamiento y la prevención de la infección por el VIH (virus de la inmunodeficiencia humana) en sujetos que padecen de la misma o corren el riesgo de contraer la infección por el VIH.
CONC2022/0013187A 2020-02-19 2022-09-15 Medicamentos antivirales para el tratamiento y prevención de la infección por vih CO2022013187A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2020107455A RU2780101C2 (ru) 2020-02-19 Противовирусные средства для лечения и профилактики вич-инфекции
PCT/RU2021/000070 WO2021167495A1 (en) 2020-02-19 2021-02-18 Pyrimidine-based bicycles as antiviral agents for the treatment and prevention of hiv infection

Publications (1)

Publication Number Publication Date
CO2022013187A2 true CO2022013187A2 (es) 2022-09-20

Family

ID=71741532

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0013187A CO2022013187A2 (es) 2020-02-19 2022-09-15 Medicamentos antivirales para el tratamiento y prevención de la infección por vih

Country Status (15)

Country Link
US (1) US20230120294A1 (es)
EP (1) EP4107156A1 (es)
JP (1) JP2023515080A (es)
KR (1) KR20220129043A (es)
CN (1) CN115279757A (es)
AU (2) AU2021224460A1 (es)
BR (1) BR112022016342A2 (es)
CA (1) CA3158698A1 (es)
CO (1) CO2022013187A2 (es)
CU (1) CU20220045A7 (es)
IL (1) IL290285A (es)
JO (1) JOP20220188A1 (es)
PE (1) PE20230559A1 (es)
WO (1) WO2021167495A1 (es)
ZA (1) ZA202207489B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115028527A (zh) * 2022-05-28 2022-09-09 汉瑞药业(荆门)有限公司 一种3-羟甲基-2,2-二甲基环丙基甲酸的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005012293D1 (de) 2004-09-28 2009-02-26 Nxp Bv Strombetriebener gleichspannungswandler
TW200626560A (en) 2004-09-30 2006-08-01 Tibotec Pharm Ltd HIV inhibiting 5-carbo-or heterocyclic substituted pyrimidines
TW200626574A (en) 2004-09-30 2006-08-01 Tibotec Pharm Ltd HIV inhibiting 5-heterocyclyl pyrimidines
RU2403254C2 (ru) 2004-10-29 2010-11-10 Тиботек Фармасьютикалз Лтд. Бициклические производные пиримидина, ингибирующие вич
MX2007010051A (es) 2005-02-18 2007-09-21 Tibotec Pharm Ltd Derivados de oxido de 2-(4-cianofenilamino)pirimidina que inhiben el virus de inmunodeficiencia humana.
PT1858861E (pt) 2005-03-04 2010-09-16 Tibotec Pharm Ltd 2-(4-cianofenil)-6-hidroxilaminopirimidinas inibidoras do hiv
CN104926829A (zh) * 2015-06-08 2015-09-23 山东大学 一种噻吩并嘧啶类衍生物及其制备方法和应用
US10370372B2 (en) * 2015-11-27 2019-08-06 Taiho Pharmaceutical Co., Ltd. Fused pyrimidine compound or salt thereof
CN106117242B (zh) * 2016-06-27 2018-08-03 山东大学 四氢噻喃并嘧啶类衍生物及其制备方法与应用
CN106749203B (zh) * 2016-11-28 2020-04-10 洛阳聚慧医药科技有限公司 一种嘧啶类杂环化合物、嘧啶类杂环化合物盐以及制备方法和应用

Also Published As

Publication number Publication date
CA3158698A1 (en) 2021-08-26
EP4107156A1 (en) 2022-12-28
KR20220129043A (ko) 2022-09-22
US20230120294A1 (en) 2023-04-20
JOP20220188A1 (ar) 2023-01-30
CN115279757A (zh) 2022-11-01
AU2021224460A1 (en) 2022-12-15
IL290285A (en) 2022-04-01
PE20230559A1 (es) 2023-03-31
WO2021167495A1 (en) 2021-08-26
RU2020107455A3 (es) 2021-05-05
RU2020107455A (ru) 2020-07-27
ZA202207489B (en) 2023-03-29
JP2023515080A (ja) 2023-04-12
AU2024200431A1 (en) 2024-02-08
CU20220045A7 (es) 2023-03-07
BR112022016342A2 (pt) 2022-10-04

Similar Documents

Publication Publication Date Title
BR112017017500A2 (pt) derivado de quinolina para uso no tratamento e prevenção de infecções virais
DOP2021000195A (es) Compuestos de carbamoyl piridona tricíclicos con puente y su uso farmacéutico
CU20110208A7 (es) Derivados de la piridina de tieno (2,3-b) como inhibidores virales de la réplica
UY36649A (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana
UY36648A (es) Inhibidores de la replicación del virus de inmunodeficiencia humana
CL2019003309A1 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue.
CL2019002745A1 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue.
SV2018005750A (es) Derivados de compuestos de indol sustituidos como inhibidores de la replicacion virica del dengue
DOP2021000062A (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
CO2022014073A2 (es) Compuestos antivirales y métodos para la administración de los mismos
CL2018002758A1 (es) Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue.
CL2019003294A1 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue.
CR20150313A (es) Composiciones farmacéuticas
CO2022013187A2 (es) Medicamentos antivirales para el tratamiento y prevención de la infección por vih
UY38559A (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana
BRPI0508428A (pt) fosfonato nucleosìdeos utilizáveis como ingredientes ativos em composições farmacêuticas para o tratamento de infecções virais e intermediários para sua produção
UY38228A (es) Compuestos de triazolopirimidina y su uso en el tratamiento del cáncer
CL2021000329A1 (es) Compuestos útiles en terapia del vih
EA202092814A1 (ru) Пиридоновое производное, его композиция и применение в качестве противовирусного лекарственного средства
CL2022002386A1 (es) Compuestos de amino pirimidina fusionados
DOP2022000171A (es) Compuestos tetracíclicos para el tratamiento de infecciones por vih
AR111464A1 (es) Terapia combinada para el tratamiento de infecciones virales
UY37555A (es) Derivados de ácido piridin-3-il-acético como inhibidores de la replicación del virus de la inmunodeficiencia humana
BR112022000971A2 (pt) Derivados de di-hidropirimidina e uso dos mesmos no tratamento de infecção por hbv ou de doenças induzidas por hbv
CL2020001353A1 (es) Pirazolopirimidinas que tienen actividad contra el vsr.